Bio-Path (BPTH) Short Interest Ratio & Short Volume $0.18 -0.02 (-7.50%) As of 11:09 AM Eastern Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends Bio-Path Short Interest DataBio-Path (BPTH) has a short interest of 79,400 shares, representing 1.38% of the float (the number of shares available for trading by the public). This marks a -56.13% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 678,130 shares to cover all short positions.Current Short Interest79,400 sharesPrevious Short Interest181,000 sharesChange Vs. Previous Month-56.13%Dollar Volume Sold Short$64,107.56Short Interest Ratio0.0 Days to CoverLast Record DateJanuary 31, 2025Outstanding Shares5,770,000 sharesFloat Size5,770,000 sharesShort Percent of Float1.38%Today's Trading Volume126,325 sharesAverage Trading Volume678,130 sharesToday's Volume Vs. Average19% Short Selling Bio-Path? Sign up to receive the latest short interest report for Bio-Path and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartBPTH Short Interest Over TimeBPTH Days to Cover Over TimeBPTH Percentage of Float Shorted Over Time Bio-Path Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 1/31/202579,400 shares $64,107.56 -56.1%1.4%0 $0.81 1/15/2025181,000 shares $153,198.40 -27.6%3.1%0.1 $0.85 12/31/2024250,000 shares $290,000.00 +189.4%5.8%0.1 $1.16 12/15/202486,400 shares $57,127.68 +179.6%2.0%0 $0.66 11/30/202430,900 shares $23,793.00 -18.9%0.7%0 $0.77 11/15/202438,100 shares $30,956.25 -51.0%0.9%0 $0.81 10/31/202477,800 shares $70,447.90 -80.0%2.1%0.1 $0.91 10/15/2024388,600 shares $446,890.00 +3,947.9%10.5%0.3 $1.15 9/30/20249,600 shares $8,735.04 -41.5%0.4%0 $0.91 9/15/202416,400 shares $16,728.00 -64.4%0.6%0 $1.02 Get the Latest News and Ratings for BPTH and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Bio-Path and its competitors with MarketBeat's FREE daily newsletter. 8/31/202446,100 shares $45,484.52 -16.6%1.8%0.1 $0.99 8/15/202455,300 shares $82,397.00 -9.6%2.2%0 $1.49 7/31/202461,200 shares $96,696.00 -45.0%2.9%0.1 $1.58 7/15/2024111,300 shares $213,696.00 -23.5%5.4%0.1 $1.92 6/30/2024145,400 shares $290,800.00 +76.0%7.0%0.1 $2.00 6/15/202482,600 shares $178,416.00 +159.8%4.0%0 $2.16 5/31/202431,800 shares $65,508.00 +32.5%2.0%0 $2.06 5/15/202424,000 shares $53,760.00 -46.0%1.5%0 $2.24 4/30/202444,400 shares $125,652.00 +62.0%2.9%0 $2.83 4/15/202427,400 shares $80,830.00 -59.4%3.6%0 $2.95 3/31/202467,400 shares $277,688.00 +6.3%9.0%2.7 $4.12 3/15/202463,400 shares $291,640.00 +284.2%9.6%3 $4.60 2/29/202416,500 shares $100,320.00 -14.5%2.7%1.7 $6.08 2/15/202419,300 shares $170,612.00 -94.9%3.1%2.9 $8.84 1/31/2024378,300 shares $162,669.00 -6.0%N/A3.5 $0.43 1/15/2024402,500 shares $201,250.00 +7.3%N/A1.7 $0.50 12/31/2023375,200 shares $173,717.60 -12.9%N/A0.1 $0.46 12/15/2023430,900 shares $202,523.00 -18.6%N/A0.2 $0.47 11/30/2023529,600 shares $296,576.00 -23.9%N/A0.2 $0.56 11/15/2023695,700 shares $371,225.52 -28.3%N/A0.3 $0.53 10/31/2023969,600 shares $639,451.20 +240.3%N/A0.4 $0.66 10/15/2023284,900 shares $213,675.00 +66.9%N/A0.1 $0.75 9/30/2023170,700 shares $63,159.00 -21.2%N/A0.5 $0.37 9/15/2023216,700 shares $88,847.00 +23.1%N/A0.6 $0.41 8/31/2023176,000 shares $72,652.80 -19.4%N/A0.5 $0.41 8/15/2023218,300 shares $82,735.70 -46.7%N/A0.7 $0.38 7/31/2023409,300 shares $433,858.00 +44.1%N/A1.4 $1.06 7/15/2023284,000 shares $369,200.00 +44.8%N/A6.9 $1.30 6/30/2023196,200 shares $349,236.00 +111.9%N/A5.8 $1.78 6/15/202392,600 shares $152,780.74 +15.3%N/A2.8 $1.65Nvidia > DeepSeek (Ad)Everyone's getting it all wrong … Sure, DeepSeek's reveal caused AI stocks to tumble … But, in the long run … that's a good thing.Click here to see why Nvidia's bad day could end up being a great year. 5/31/202380,300 shares $132,495.00 +7.5%N/A3 $1.65 5/15/202374,700 shares $112,050.00 +6.1%N/A2.5 $1.50 4/30/202370,400 shares $99,264.00 -15.8%N/A2.3 $1.41 4/15/202383,600 shares $116,195.64 +10.0%N/A2.4 $1.39 3/31/202376,000 shares $105,640.00 +18.6%N/A2.1 $1.39 3/15/202364,100 shares $96,150.00 -9.7%N/A1.7 $1.50 2/28/202371,000 shares $128,510.00 +59.2%N/A1.8 $1.81 2/15/202344,600 shares $88,018.10 +49.7%N/A1.1 $1.97 1/31/202329,800 shares $61,984.00 +122.4%N/A0.4 $2.08 1/15/202313,400 shares $23,986.00 -53.2%N/A0.2 $1.79 12/30/202228,600 shares $43,186.00 -21.6%N/A0.5 $1.51 12/15/202236,500 shares $54,385.00 +644.9%N/A0.6 $1.49 11/30/20224,900 shares $7,203.00 -84.9%N/A0.1 $1.47 11/15/202232,500 shares $49,725.00 -5.3%N/A0.6 $1.53 10/31/202234,300 shares $111,475.00 +0.3%2.0%0.8 $3.25 10/15/202234,200 shares $110,466.00 -0.9%2.0%2 $3.23 9/30/202234,500 shares $110,055.00 -7.0%2.0%1.7 $3.19 9/15/202237,100 shares $139,867.00 -13.3%2.2%1.3 $3.77 8/31/202242,800 shares $156,648.00 -11.0%2.5%1.4 $3.66 8/15/202248,100 shares $198,653.00 -7.5%2.8%1.4 $4.13 7/31/202252,000 shares $185,120.00 -2.1%3.0%1.4 $3.56 7/15/202253,100 shares $221,427.00 -13.4%3.1%1.3 $4.17 6/30/202261,300 shares $237,231.00 -31.1%3.6%0.9 $3.87 6/15/202288,900 shares $321,818.00 +8.2%5.2%1.3 $3.62 5/31/202282,200 shares $293,454.00 -17.8%N/A1.2 $3.57 5/15/2022100,000 shares $304,000.00 +47.9%N/A1.5 $3.04 4/30/202267,600 shares $198,068.00 -29.7%N/A1.1 $2.93 4/15/202296,200 shares $290,524.00 +60.1%N/A1.5 $3.02 3/31/202260,100 shares $230,784.00 -31.9%N/A1.7 $3.84 3/15/202288,300 shares $264,017.00 -19.7%N/A1.9 $2.99 2/28/2022110,000 shares $412,500.00 -0.5%N/A1.8 $3.75 2/15/2022110,600 shares $436,870.00 -16.5%N/A1.3 $3.95 1/31/2022132,400 shares $450,160.00 +7.3%N/A1.5 $3.40 1/15/2022123,400 shares $486,751.30 -15.2%N/A1.2 $3.94 12/31/2021145,500 shares $548,535.00 -15.3%N/A1.5 $3.77 12/15/2021171,800 shares $723,278.00 +100.9%N/A1.8 $4.21 11/30/202185,500 shares $378,765.00 -38.4%N/A0.9 $4.43 11/15/2021138,900 shares $647,274.00 +6.4%N/A0.1 $4.66 10/29/2021130,600 shares $619,044.00 +96.7%N/A0.1 $4.74 10/15/202166,400 shares $343,288.00 +14.5%1.0%0.1 $5.17 9/30/202158,000 shares $297,540.00 -11.0%0.8%0.1 $5.13 9/15/202165,200 shares $339,040.00 -70.5%0.9%0.1 $5.20 8/31/2021221,300 shares $1.26 million +138.5%3.2%0.2 $5.68 8/13/202192,800 shares $604,128.00 -20.1%1.3%0.5 $6.51 7/30/2021116,100 shares $743,040.00 -19.5%1.7%0.6 $6.40 7/15/2021144,300 shares $903,318.00 -28.5%2.1%0.6 $6.26 6/30/2021201,800 shares $1.35 million -15.3%2.9%0.8 $6.67 6/15/2021238,300 shares $1.53 million -12.6%3.5%0.4 $6.43 5/28/2021272,600 shares $1.55 million -0.6%4.0%0.5 $5.70 5/14/2021274,200 shares $1.41 million +20.6%N/A0.4 $5.13Nvidia > DeepSeek (Ad)Everyone's getting it all wrong … Sure, DeepSeek's reveal caused AI stocks to tumble … But, in the long run … that's a good thing.Click here to see why Nvidia's bad day could end up being a great year. 4/30/2021227,300 shares $1.39 million -2.5%N/A0.1 $6.10 4/15/2021233,100 shares $1.44 million +208.7%N/A0.1 $6.17 3/31/202175,500 shares $518,685.00 -39.7%N/A0 $6.87 3/15/2021125,100 shares $935,748.00 +11.9%N/A0.1 $7.48 2/26/2021111,800 shares $722,228.00 -76.4%N/A0.1 $6.46 2/12/2021474,200 shares $4.50 million +88.6%N/A0.2 $9.50 1/29/2021251,400 shares $1.03 million +3.5%N/A0.9 $4.08 1/15/2021242,900 shares $981,316.00 -3.9%N/A0.8 $4.04 12/31/2020252,800 shares $920,192.00 -5.4%N/A0.2 $3.64 12/15/2020267,200 shares $999,328.00 +10.5%N/A0.3 $3.74 11/30/2020241,800 shares $846,300.00 +6.9%N/A0.2 $3.50 11/15/2020226,100 shares $757,435.00 +92.4%N/A0.2 $3.35 10/30/2020117,500 shares $399,500.00 +2,117.0%N/A0.1 $3.40 10/15/20205,300 shares $22,154.00 -50.9%N/A0 $4.18 9/30/202010,800 shares $45,792.00 -76.9%N/A0.1 $4.24 9/15/202046,800 shares $203,580.00 -16.6%N/A0.3 $4.35 8/31/202056,100 shares $241,230.00 +516.5%N/A0.3 $4.30 8/14/20209,100 shares $45,045.00 +11.0%N/A0.1 $4.95 7/31/20208,200 shares $41,574.00 -16.3%N/A0.1 $5.07 7/15/20209,800 shares $48,412.00 -36.0%N/A0.1 $4.94 6/30/202015,300 shares $78,336.00 +62.8%N/A0.2 $5.12 6/15/20209,400 shares $49,256.00 No ChangeN/A0.1 $5.24 5/29/20209,400 shares $51,982.00 -49.7%N/A0.1 $5.53 5/15/202018,700 shares $89,386.00 +65.5%N/A0.2 $4.78 4/30/202011,300 shares $58,308.00 -41.2%N/A0.1 $5.16 4/15/202019,200 shares $111,168.00 -59.2%N/A0.2 $5.79 3/31/202047,000 shares $269,310.00 -18.0%N/A0.4 $5.73 3/13/202057,300 shares $268,737.00 -5.8%2.1%0.5 $4.69 2/28/202060,800 shares $207,328.00 +15.6%2.3%0.6 $3.41 BPTH Short Interest - Frequently Asked Questions What is Bio-Path's current short interest? Short interest is the volume of Bio-Path shares that have been sold short but have not yet been covered or closed out. As of January 31st, investors have sold 79,400 shares of BPTH short. 1.38% of Bio-Path's shares are currently sold short. Learn More on Bio-Path's current short interest. Which institutional investors are shorting Bio-Path? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Bio-Path: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Bio-Path? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.38% of Bio-Path's floating shares are currently sold short. Is Bio-Path's short interest increasing or decreasing? Bio-Path saw a decrease in short interest in the month of January. As of January 31st, there was short interest totaling 79,400 shares, a decrease of 56.1% from the previous total of 181,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Bio-Path's float size? Bio-Path currently has issued a total of 5,770,000 shares. Some of Bio-Path's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Bio-Path currently has a public float of 5,770,000 shares. How does Bio-Path's short interest compare to its competitors? 1.38% of Bio-Path's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Bio-Path: Athira Pharma, Inc. (2.69%), GlycoMimetics, Inc. (3.15%), Affimed (5.29%), Spruce Biosciences, Inc. (0.60%), HCW Biologics Inc. (0.42%), Synlogic, Inc. (0.77%), NeuroSense Therapeutics Ltd. (1.13%), Eagle Pharmaceuticals, Inc. (2.90%), ImmunoPrecise Antibodies Ltd. (1.79%), GeoVax Labs, Inc. (5.96%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.21 billion), Charter Communications, Inc. ($4.07 billion), Reddit, Inc. ($3.33 billion), The Kroger Co. ($2.67 billion), Cencora, Inc. ($2.29 billion), Hims & Hers Health, Inc. ($2.17 billion), SoFi Technologies, Inc. ($1.99 billion), Live Nation Entertainment, Inc. ($1.87 billion), Rivian Automotive, Inc. ($1.76 billion), and Moderna, Inc. ($1.60 billion). View all of the most shorted stocks. What does it mean to sell short Bio-Path stock? Short selling BPTH is an investing strategy that aims to generate trading profit from Bio-Path as its price is falling. BPTH shares are trading up $0.07 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Bio-Path? A short squeeze for Bio-Path occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of BPTH, which in turn drives the price of the stock up even further. How often is Bio-Path's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BPTH, twice per month. The most recent reporting period available is January, 31 2025. More Short Interest Resources from MarketBeat Related Companies ATHA Short Squeeze GLYC Short Squeeze AFMD Short Squeeze SPRB Short Squeeze HCWB Short Squeeze SYBX Short Squeeze NRSN Short Squeeze EGRX Short Squeeze IPA Short Squeeze GOVX Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:BPTH) was last updated on 2/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon “obliterates” Bill Gates?All 10 of the world's biggest money managers follow my work, and the Pentagon, the FBI and Harvard professors ...Altimetry | SponsoredNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored My 2025 AI BlueprintI first recommended Bitcoin at $300 in 2013 … before it went up 33,645%. Now, I am revealing my 2025 AI Blu...Weiss Ratings | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredBetter than Bitcoin – and potentially more profitableThe world is obsessed with Bitcoin again... And for a good reason: It just soared beyond $100,000. Bitcoin ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bio-Path Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bio-Path With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BPTH Stock Alerts